Steris (STE) Tops Q4 EPS by 15c; Offers FY23 Outlook

Steris (NYSE: STE) reported Q4 EPS of $2.30, $0.15 better than the analyst estimate of $2.15. Revenue for the quarter came in at $1.38 billion versus the consensus estimate of $1.27 billion.

GUIDANCE:

Steris sees FY2023 EPS of $8.55-$8.75, versus the consensus of $8.05.

For earnings history and earnings-related data on Steris (STE) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained
• Barclays says AI trade is maturing, favors greater diversification